Monday miscellany

This Kat dined tonight at Concert Noble, the impressive venue chosen by the Pharmaceutical Trade Marks Group for its Spring conference. Attending this event, he has been reminded how much can be learned from participating in sector-specific gatherings and listening to some well informed comments as to how trade marks in particular, and intellectual property rights as a whole, influence patterns of investment, research, development and consumption within the confines of the pharma and healthcare markets.  Though we have a one-size-fits-all trade mark law, we should be ever mindful that, while the essential and subsidiary functions of the trade mark remain constant, the role of the trade mark varies considerably across industries as diverse as pharmaceuticals, fashion, foodstuffs, the banking and professional services sectors and the sports and entertainment industries.

The IPKat's ever-industrious friend Enrico Bonadio has produced another paper which is available on SSRN here: it's "Stem Cells Industry and Beyond: What is the Aftermath of Brüstle?".  Published in the European Journal of Risk Regulation, Vol. 1, pp. 93-97, 2012, Enrico's article focuses on the ruling of the Court of Justice of the European Union in Case C-34/10 Brüstle v Greenpeace (noted here). Enrico asks whether this ruling might expose the EU and some of its Member States to a WTO challenge for failing to comply with Article 27(2) TRIPS as well as whether the decision may might be invoked to oppose the issuance, or challenge the validity, of any patent obtained through immoral or unlawful activities.

Around the weblogs. The 40th stage of Kingsley Egbuonu's A to Z marathon trek round official African IP websites for Afro-IP takes him to São Tomé and Príncipe -- where there aren't any. "Blogs to pay royalties for posting YouTube videos – Oh Dear!" is the title of Patricia Covarrubia's post on IP Tango about latest news from Brazil. IP Finance looks forward to further details of the UK's Patent Box..
Monday miscellany Monday miscellany Reviewed by Jeremy on Monday, March 19, 2012 Rating: 5

No comments:

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here:

Powered by Blogger.